IPERBOREAL PHARMA SRL
๐ฎ๐นItaly
- Country
- ๐ฎ๐นItaly
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.iperboreal.com
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
Phase 2
Withdrawn
- Conditions
- End Stage Renal Disease (ESRD)
- Interventions
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 10
- Registration Number
- NCT04086212
Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD
Phase 2
Terminated
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitineDrug: 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 11
- Registration Number
- NCT04001036
- Locations
- ๐ฎ๐น
Department of Nephrology, University of Chieti, Chieti, Italy
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Phase 3
Recruiting
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High StrenghtDrug: 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 170
- Registration Number
- NCT03994471
- Locations
- ๐ฎ๐น
Ospedale SS. Annunziata, Chieti, Italy
๐ฎ๐นIRCCS Policlinico San Martino, Genova, Italy
๐ฎ๐นOspedale Civile San Salvatore, L'Aquila, Italy
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
Phase 1
Recruiting
- Conditions
- Congestive Heart Failure
- Interventions
- Drug: PolyCore (Polydextrin, L-Carnitine, D-xylitol)
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 84
- Registration Number
- NCT03994874
- Locations
- ๐ฎ๐น
Ospedale Ss. Annunziata, Chieti, Italy
๐ฎ๐นASST FBF Sacco, Milano, Italy
๐ฎ๐นOspedale Monaldi, Napoli, Italy
L-Carnitine in Peritoneal Dialysis
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 4
- Registration Number
- NCT00922701
- Locations
- ๐ฎ๐น
Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy
Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
Phase 2
Withdrawn
- Conditions
- End-Stage Renal Disease
- Interventions
- Drug: PD solution for diurnal exchangesDrug: PD solution for nocturnal exchanges
- First Posted Date
- 2009-03-09
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Iperboreal Pharma Srl
- Registration Number
- NCT00858182
L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 5
- Registration Number
- NCT00851838
- Locations
- ๐ฎ๐น
Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy
Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Phase 2
Completed
- Conditions
- End Stage Renal DiseaseInsulin Resistance
- Interventions
- Drug: PD solution containing glucose
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Iperboreal Pharma Srl
- Target Recruit Count
- 35
- Registration Number
- NCT00755456
- Locations
- ๐ฎ๐น
Renal and Dialysis, Bari Policlinic Hospital, Bari, Italy
๐ฎ๐นRenal, Dialysis and Transplant Unit, University of Bari, Bari, Italy
๐ฎ๐นDivision of Nephrology, University of "G. d'Annunzio", Chieti, Italy
Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Phase 2
Withdrawn
- Conditions
- End Stage Renal DiseaseDiabetes
- Interventions
- Drug: PD SolutionDrug: PD solution containing L-carnitine
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Iperboreal Pharma Srl
- Registration Number
- NCT00755404
- Locations
- ๐ฎ๐น
Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore, Milano, Italy
๐ฎ๐นDivision of Nephrology and Dialysis, "Mazzini" Hospital, Teramo, Italy
๐ฎ๐นNephrology and Dialysis Unit, Desio Hospital, Desio, Italy
ยฉ Copyright 2025. All Rights Reserved by MedPath